IMPEDIMED LIMITED — Capital/Financing Update 2023

May 17, 2023

Market Announcement

==> picture [33 x 50] intentionally omitted <==

18 May 2023

==> picture [451 x 5] intentionally omitted <==

ImpediMed Limited (ASX: IPD) – Trading Halt

Description

The securities of ImpediMed Limited (‘IPD’) will be placed in trading halt at the request of IPD, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Monday, 22 May 2023 or when the announcement is released to the market.

Issued by

Zufishan Anjum

Senior Adviser (Accounting), Listings Compliance

Market Announcement 1/1 ASX Customer Service Centre 131 279 | asx.com.au

18 May 2023 ASX Limited

==> picture [215 x 68] intentionally omitted <==

18 May 2023

Zufishan Anjum Advisor, Listings Compliance ASX Compliance Pty Ltd 20 Bridge Street Sydney NSW 2000

Dear Ms Anjum,

Request for Trading Halt – ImpediMed Limited

Pursuant to ASX Listing Rule 17.1, ImpediMed Limited (ASX: IPD) ( ImpediMed ) requests an immediate trading halt be granted by ASX Limited with respect to its shares ( ASX Code: IPD ) to apply from the commencement of trading today, Thursday, 18 May 2023.

The trading halt is requested in connection with a proposed capital raising.

The following information is provided in accordance with ASX Listing Rule 17.1:

1. Reason for trading halt – to avoid trading taking place on an uninformed basis and to allow the capital raising to take place in an orderly manner.

2. Duration of the trading halt – ImpediMed requests that the trading halt remain in place until the earlier of:

   • (i) ImpediMed making an announcement to the market regarding the outcome of the proposed capital raising; and

   • (ii) the commencement of trading on Monday, 22 May 2023.

3. No reason – ImpediMed is not aware of any reason why the trading halt should not be granted.

4. Further information – none.

Should you have any questions, please do not hesitate to contact me on +61 414 731 082.

Yours sincerely,

Leanne Ralph Company Secretary

ImpediMed Ltd ● ABN 65 089 705 144 ● TEL: +61 (0)7 3860 3700 FAX: 61 (0)7 3260 1225 ● FREE CALL: 1800 638 477 ● EMAIL: enquiries@impedimed.com